UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management

PloS one, 2022-03, Vol.17 (3), p.e0264307-e0264307

2022

Link zum Volltext

Verfügbarkeit prüfen

A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry

Hepatology communications, 2024-06, Vol.8 (6)

2024

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune hepatitis: Current and future therapies

Hepatology communications, 2024-06, Vol.8 (6)

2024

Link zum Volltext

Verfügbarkeit prüfen

Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies

Current hepatology reports, 2018-09, Vol.17 (3), p.166-174

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic and Environmental Risk Factors for Autoimmune Hepatitis

Clinical liver disease (Malden, Mass.), 2019-07, Vol.14 (1), p.29-32

Lammert, Craig

2019

Link zum Volltext

Verfügbarkeit prüfen

Relationship between daily dose of oral medications and idiosyncratic drug‐induced liver injury: Search for signals

Hepatology (Baltimore, Md.), 2008-06, Vol.47 (6), p.2003-2009

2008

Link zum Volltext

Verfügbarkeit prüfen

Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1246-S-1247

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury

Clinical gastroenterology and hepatology, 2019-12, Vol.17 (13), p.2814-2815

2019

Link zum Volltext

Verfügbarkeit prüfen

Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface

Journal of hepatology, 2024-07, Vol.81 (1), p.e45-e47

2024

Link zum Volltext

Verfügbarkeit prüfen

Unexplained liver test elevations after SARS-CoV-2 vaccination

Journal of hepatology, 2022-07, Vol.77 (1), p.251-253

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.615-620

2010

Link zum Volltext

Verfügbarkeit prüfen

Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients

Digestive diseases and sciences, 2022-07, Vol.67 (7), p.2891-2898

2022

Link zum Volltext

Verfügbarkeit prüfen

Mo1617 HIGHER BURDEN OF UNMET NEEDS AND DIMINISHED QUALITY OF LIFE IN WOMEN WITH AUTOIMMUNE HEPATITIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1060-S-1061

2024

Link zum Volltext

Verfügbarkeit prüfen

Mo1462 - A Novel Approach Using Social Media to Investigate Patientcentric Data in Autoimmune Hepatitis

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1214-S-1214

2018

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis

Digestive diseases and sciences, 2020-01, Vol.65 (1), p.322-328

2020

Link zum Volltext

Verfügbarkeit prüfen

Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life

Digestive diseases and sciences, 2023-01, Vol.68 (1), p.77-86

2023

Link zum Volltext

Verfügbarkeit prüfen

1185 AIH-MASLD OVERLAP IS PREVALENT IN A NORTH AMERICAN AIH COHORT BUT HAS SIMILAR CLINICAL FEATURES AND OUTCOMES AS AIH ALONE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1569-S-1569

2024

Link zum Volltext

Verfügbarkeit prüfen

Mo1588 BIOCHEMICAL REMISSION IN MALE AUTOIMMUNE HEPATITIS PATIENTS IS LESS FREQUENT THAN FEMALES DESPITE INCREASED USE OF CORTICOSTEROIDS AND SECOND LINE TREATMENTS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1703-S-1704

2024

Link zum Volltext

Verfügbarkeit prüfen

Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic

Journal of investigative medicine, 2021-12, Vol.69 (8), p.1426-1433

2021

Link zum Volltext

Verfügbarkeit prüfen

Tu1530 – Use of Cannabidiol (CBD Oil) in Autoimmune Hepatitis - What are the Patients Doing?

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1355-S-1355

2019

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune hepatitis and metabolic syndrome‐associated disease development: a U.S. cohort study

Alimentary pharmacology & therapeutics, 2022-10, Vol.56 (7), p.1183-1193

2022

Link zum Volltext

Verfügbarkeit prüfen

Black Adult Patients With Acute Liver Failure Are Sicker and More Likely to Undergo Liver Transplantation Than White Patients

Liver transplantation, 2019-11, Vol.25 (11), p.1634-1641

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient Reported Outcomes of Physical and Psychological Suffering in Patients With Autoimmune Hepatitis: 1002

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S562

2018

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Steatosis Is Highly Prevalent but Is Not Correlated With Advanced Fibrosis in Autoimmune Hepatitis: Results Obtained at the Autoimmune Hepatitis Association National Meeting: 947

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S530-S531

2018

Link zum Volltext

Verfügbarkeit prüfen

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis

Medicine (Baltimore), 2020-10, Vol.99 (42), p.e22805-e22805

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management

A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry

Autoimmune hepatitis: Current and future therapies

Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies

Genetic and Environmental Risk Factors for Autoimmune Hepatitis

Relationship between daily dose of oral medications and idiosyncratic drug‐induced liver injury: Search for signals

Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT

Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury

Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface

Unexplained liver test elevations after SARS-CoV-2 vaccination

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients

Mo1617 HIGHER BURDEN OF UNMET NEEDS AND DIMINISHED QUALITY OF LIFE IN WOMEN WITH AUTOIMMUNE HEPATITIS

Mo1462 - A Novel Approach Using Social Media to Investigate Patientcentric Data in Autoimmune Hepatitis

Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis

Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life

1185 AIH-MASLD OVERLAP IS PREVALENT IN A NORTH AMERICAN AIH COHORT BUT HAS SIMILAR CLINICAL FEATURES AND OUTCOMES AS AIH ALONE

Mo1588 BIOCHEMICAL REMISSION IN MALE AUTOIMMUNE HEPATITIS PATIENTS IS LESS FREQUENT THAN FEMALES DESPITE INCREASED USE OF CORTICOSTEROIDS AND SECOND LINE TREATMENTS

Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic

Tu1530 – Use of Cannabidiol (CBD Oil) in Autoimmune Hepatitis - What are the Patients Doing?

Autoimmune hepatitis and metabolic syndrome‐associated disease development: a U.S. cohort study

Black Adult Patients With Acute Liver Failure Are Sicker and More Likely to Undergo Liver Transplantation Than White Patients

Patient Reported Outcomes of Physical and Psychological Suffering in Patients With Autoimmune Hepatitis: 1002

Hepatic Steatosis Is Highly Prevalent but Is Not Correlated With Advanced Fibrosis in Autoimmune Hepatitis: Results Obtained at the Autoimmune Hepatitis Association National Meeting: 947

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis

Suchergebnisse filtern